A monster in my medicine chest? Could this be by design

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
128
A monster in my medicine chest?

Could this be by design by the pharma thugs?

New Study Unearths Paradox: Opioids Cause Chronic Pain

http://www.greenmedinfo.com/blog/new-study-un...ronic-pain

We all know that surgery is often painful, but a new study will have you thinking twice before you fill that pain-pill prescription. As this new science reveals, even a few days of opiates can set you up for a longer, more painful recovery

A just-released study has called into question the feasibility of using opioids to manage post-surgical pain. Rats given repeated doses of morphine experienced inflammation and pain for three weeks longer than non-medicated test subjects.

On April 16, 2018, researchers from the University of Colorado at Boulder released an animal study[1] examining the effect of opioids on pain, post-surgery. In the study, an exploratory abdominal surgery was conducted on male rats called a laparotomy. Laparotomies are routine surgical procedures in the United States, often conducted when pelvic disorders are suspected, and one for which opioids are the standard post-surgical pain management prescription.

Rats were treated with moderate doses of morphine immediately post-surgery for seven days, while a control group was given saline solution. A further experiment was conducted to determine the effects of two-days of gradual tapering from morphine after eight days of dosing, versus the effects of abrupt withdrawal. A third experiment fed subjects morphine for seven days prior to laparotomy. Rats were then measured for sensitivity to touch, as well as expression of inflammatory markers in the spinal cord.

In a surprise to researchers, results showed that opioid pain treatments prolonged pain for three weeks as compared to non-medicated subjects given the saline solution. Opioids further had the effect of “priming” specialized, immune system cells in the spinal cord to become more sensitive to pain. The longer the rats received morphine, the longer they were reactive to pain. Tapering from the medication had no effect on pain sensitivity as compared to quitting cold-turkey. Researchers concluded that “morphine can have a deleterious effect on postoperative pain,” and suggested that longitudinal studies be performed to determine if this same effect can be seen in humans.

In an interview with Science Daily, the study authors are well-aware of the implications for current pain-management procedures in most hospitals and pain clinics, as well as how this study might impact the nationwide debate about opioid abuse. According to senior author Linda Watkins, "This indicates that there is another dark side of opiates that many people don't suspect. It shows that trauma, including surgery, in combination with opiates can lead to chronic pain."

Professor Watkins describes a “one-two hit” on the immune system, that comes first from the surgery, and then from the opioid medication, sending repeat signals to the body that it is “not OK.” It’s as if the morphine is perceived by the body as a secondary threat, coming at a time when it is already compromised. Watkins describes the primed response by glial cells, stating that they create “a more enduring state of inflammation and sometimes local tissue damage,” problems only experienced by the rats exposed to morphine.

This opens the door to a broader methodological debate about how the body—and Western medicine—manages pain. Are opioids, if not all pharmaceutical medications, hijacking the body’s innate response systems? Millions of years of evolution have created a natural intelligence that is far superior to the medical interventions that mankind implements. Are prescriptions for pain-management merely shooting us in our collective foot?

This study is not alone in its findings. A 2016 animal study[2] found that only a few days treatment with opioids for chronic nerve pain intensified and prolonged pain for months due to increased systemic inflammation. There are limited human studies that also support reexamining opiates.[3],[4] The nation’s ongoing opioid crisis undoubtedly supports the need for immediate exploration of non-addictive, holistic treatments for pain.

Researchers admit that the intention behind opioid therapy is to limit pain and suffering—not prolong it—and that more human studies are necessary to determine if alternative painkillers can effectively replace opioids, without the negative side effects.

For additional reasearch on Natural Remedies for Pain, visit the GreenMedInfo database on the subject.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HANGCHA's AI-Fork Revolution: Bold Steps to 2030

Updated Category News Views 115

Forklifts and the Future: A Fork in the Road for HANGCHA There's a movement happening, folks, and I don't mean in the usual stock ticker shift way. We're talking forklifts here—AI-powered, no less. HANGCHA Group, a name that may or may not roll off the tongue but sure makes waves in manufacturing, just held its 4th Global Dealers Conference in Hangzhou, China. If you're...

Continue Reading
CGI Shines with Strong Q4, Announces Dividend Hike

Updated Category News Views 71

CGI Records Impressive Fourth Quarter Growth Well, CGI's got reason to strut its stuff this time around. Clocked in with a fourth-quarter revenue of $4.15 billion - that's a nice 3.3% bump up year-over-year, if you leave the currency noise out of it, it's about 2.5%. The real kicker? Net earnings shot up 20.8%. In a world where everyone’s fighting over scraps, these...

Continue Reading
Replit Wins 2026 Microsoft Startup Partner Award

Updated Category News Views 65

Replit's Triumph in the Microsoft Ecosystem If there's one thing you come to expect from this dizzying dance of technology and business, it's that standout players get their due when they push the envelope. Replit just snagged a gleaming accolade by being named Microsoft's 2026 Partner of the Year for Startups. That's a hefty badge, especially coming from a giant like...

Continue Reading
Oracle's Opower Drives Record Utility Success in 2026

Updated Category News Views 124

Peak Performance: Oracle Opower's Latest Surge Hey, energy watchers, if you don't have Oracle Opower on your radar, it might be time for a check-up! These folks have achieved more peak energy demand reduction this year than you've seen in quite some time. We're talking 1 gigawatt reduced across 70-plus events, no less. Wrap your head around that for a minute! That's like...

Continue Reading
Lake Victoria Gold Kicks Off Imwelo Drilling Program

Updated Category News Views 120

Drill Bit Meets Tanzanian Rock: Lake Victoria's Next Move It's not every day you hear about a company plunging rotary bits into African soil with as much gusto as Lake Victoria Gold, eh? The folks over at LVG have decided it's time to hit the ground—or rather, dig into it—with an ambitious 6,500-meter grade control drilling program at their Imwelo Gold Project in...

Continue Reading
Group 1 Expands with Porsche Atlanta Northwest Acquisition

Updated Category News Views 87

Porsche Atlanta Northwest Joins Group 1 Automotive This ain't just some humdrum industry announcement, folks. Group 1 Automotive, the Houston-based heavyweight, has tightened its grip on the Atlanta car scene by welcoming Porsche Atlanta Northwest into the fold. This development marks the latest notch in Group 1’s belt as they continue gobbling up Atlanta-area...

Continue Reading
Virginia Water Alerts: Serving 384K with Flow Tips

Updated Category News Views 78

Keeping Water Flowing Smoothly in Virginia Water's one of those things you hardly notice until it's not there—or worse, when it throws a wrench in your usual routine. Virginia American Water, a branch of the big-dog utility American Water (NYSE: AWK), is trying its darndest to keep folks from missing a beat. They offer up some sage advice on staying plugged into the...

Continue Reading
Webull Faces Class Action Over China Ties Missteps

Updated Category News Views 79

What's Brewing with Webull? Troubling allegations have bubbled to the surface regarding Webull Corporation, now in the crosshairs of a securities class action. The heart of this legal storm is the claim that Webull, under the ticker NASDAQ:BULL, allegedly disguised its deep-seated ties with China. And boy, when those revelations hit the news on October 7, 2026, it sent...

Continue Reading
PHFA Unveils 2027/2028 Plan for Housing Tax Credits

Updated Category News Views 33

Fresh Blueprint for Affordable Housing in Pennsylvania Alright, folks, it's time we talk about something other than Wall Street hype: the nitty-gritty of housing, but not just any housing. I'm talking about low-income housing and what Pennsylvania's Housing Finance Agency (PHFA) has cooked up for us. They’ve released their much-anticipated 2027/2028 Qualified Allocation...

Continue Reading
Vipboss Offers Big Black Friday Deals for Adventurers

Updated Category News Views 57

Anticipating Next Year’s Adventures Today Outdoor enthusiasts, listen up! Just because the frost is nipping at your nose doesn’t mean you can’t start dreaming about where the open road or sea will take you next. Vipboss, a known figure in the world of reliable power solutions, is rolling out a Black Friday bonanza, ready to electrify your preparation game with...

Continue Reading

Top 5 Most Recently Viewed Articles

Jome Secures $9.8 Million in Series A Funding to Advance Home Buying

Updated Category News Views 459

Jome Secures $9.8 Million in Series A Funding to Advance Home Buying Jome, an innovative AI-powered real estate marketplace aiming to transform the home-buying experience for new construction properties, has successfully raised $9.8 million in a Series A funding round. The funding was spearheaded by Geek Ventures, with contributions from U.Ventures, Toloka VC, and...

Continue Reading
Blue Owl Capital Investors Urged To Act Amid Legal Challenges

Updated Category News Views 209

Legal Concerns Surrounding Blue Owl Capital Inc. Recently, significant legal developments have come to light regarding Blue Owl Capital Inc. This class action lawsuit raises serious allegations against the company, prompting investors to take notice. As you navigate this complex situation, being informed about your rights is crucial. Understanding the Class Action Lawsuit...

Continue Reading
Fnac Darty's Strategic Offer for Unieuro Shares Explained

Updated Category News Views 121

Fnac Darty's Voluntary Public Tender for Unieuro Shares In a significant move in the retail sector, Fnac Darty SA has initiated a voluntary public tender and exchange offer to acquire all shares of Unieuro S.p.A. This strategic undertaking is pertinent for both companies as they aim to align their market positions and enhance shareholder value. Details of the Offer The...

Continue Reading
Integrum Welcomes Martin Hillsten as New CEO to Drive Growth

Updated Category News Views 210

Integrum Appoints Martin Hillsten as New CEO Integrum AB (publ) has recently announced the appointment of Martin Hillsten as its new Chief Executive Officer, effective immediately. Martin takes over from Scott Flora, who served as acting CEO and will continue to provide support for US marketing efforts in an advisory role while remaining on the Board of Directors....

Continue Reading
Baker Hughes Schedules Q3 Earnings Call for Investors and Media

Updated Category News Views 161

Baker Hughes' Upcoming Earnings Announcement Baker Hughes, a leading energy technology company, is set to unveil its third-quarter financial results. This announcement is scheduled following the conclusion of the quarter, which ends on September 30. The firm will disseminate its earnings report on the designated day at 5 p.m. Eastern Time. Details of the Earnings Release...

Continue Reading